IP6K3 抗体 (Internal Region)
-
- 抗原 See all IP6K3 抗体
- IP6K3 (Inositol Hexakisphosphate Kinase 3 (IP6K3))
-
抗原表位
- Internal Region
-
适用
- 人
-
宿主
- 山羊
-
克隆类型
- 多克隆
-
标记
- This IP6K3 antibody is un-conjugated
-
应用范围
- ELISA, Western Blotting (WB)
- 原理
- IP6K3
- 序列
- KESQEPFKVS TES
- 特异性
- This antibody is expected to recognize. Reported variants represent identical protein: NP_001136355.1, NP_473452.2
- 交叉反应
- 人
- 纯化方法
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- 质量等级
- Verified
- 亚型
- IgG
- Top Product
- Discover our top product IP6K3 Primary Antibody
-
anti-Inositol Hexakisphosphate Kinase 3 (IP6K3) (Internal Region) antibody
IP6K3 适用: 人, 小鼠, 大鼠 ELISA, WB, IHC, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Inositol Hexakisphosphate Kinase 3 (IP6K3) antibodyIP6K3 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Inositol Hexakisphosphate Kinase 3 (IP6K3) (Internal Region) antibodyIP6K3 适用: 人 ELISA, WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Inositol Hexakisphosphate Kinase 3 (IP6K3) (Internal Region) antibodyIP6K3 适用: 人, 小鼠 ELISA, WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Inositol Hexakisphosphate Kinase 3 (IP6K3) (AA 201-250) antibodyIP6K3 适用: 人, 小鼠 ELISA, WB, IHC 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
Western Blot: Approx 45 kDa band observed in Human Kidney lysates (calculated MW of 46.4 kDa according to NP_473452.2). Recommended concentration: 1-3 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:128000.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 0.5 mg/mL
- 缓冲液
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Minimize freezing and thawing.
- 储存条件
- -20 °C
- 储存方法
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
